E-viri
Recenzirano
Odprti dostop
-
Sopek-Merkaš, Ivana; Lakušić, Nenad; Fučkar, Krunoslav; Cerovec, Duško; Bešić, Kristina Marić
Acta clinica Croatica, 09/2021, Letnik: 60, Številka: 3Journal Article
Antiplatelet therapy is an integral part of optimal medicamentous therapy in patients with coronary artery disease. The strategy of antiplatelet/anticoagulant therapy is adjusted (combination of drugs, dosing and duration of therapy) depending on the stage of the disease (acute coronary syndrome with percutaneous coronary intervention, chronic coronary syndrome, or coronary surgical revascularization) and comorbidity of each patient (e.g., atrial fibrillation, left ventricular thrombus, etc.). Guidelines and clinical practice in particular are not uniform and specific regarding dual antiplatelet therapy in patients undergoing coronary artery bypass grafting, especially in the setting of chronic coronary syndrome.
